Literature DB >> 18453602

IL-6-dependent mucosal protection prevents establishment of a microbial niche for attaching/effacing lesion-forming enteric bacterial pathogens.

Sara M Dann1, Martina E Spehlmann, Dustin C Hammond, Mitsutoshi Iimura, Koji Hase, Lillian J Choi, Elaine Hanson, Lars Eckmann.   

Abstract

Enteric infections with attaching/effacing lesion-inducing bacterial pathogens are a worldwide health problem. A murine infection model with one such pathogen, Citrobacter rodentium, was used to elucidate the importance of the pleiotropic immune regulator, IL-6, in the pathogenesis of infection. IL-6 was strongly induced in colonic epithelial cells and macrophages upon C. rodentium infection and was required for effective host defense, because mice lacking IL-6 failed to control bacterial numbers 2-3 wk after infection and exhibited increased mortality. IL-6 was not needed for mounting effective T and B cell responses to the pathogens, nor was it important for induction of IFN-gamma or TNF-alpha, cytokines involved in host defense against the bacteria, or the antibacterial effector, NO. Instead, IL-6 played a key role in mucosal protection, since its absence was associated with marked infection-induced apoptosis in the colonic epithelium and subsequent ulcerations. Cell culture studies confirmed that IL-6 protected colon epithelial cells directly against inducible apoptosis, which was accompanied by increased expression of an array of genes encoding antiapoptotic proteins, including Bcl-x(L), Mcl-1, cIAP-2, and Bcl-3. Ulcerations appeared to be pathogenetically important, because bacteria localized preferentially to those regions, and chemically induced colonic ulcerations promoted bacterial colonization. Furthermore, blood components likely present in ulcer exudates, particularly alanine, asparagine, and glycine, promoted bacterial growth. Thus, IL-6 is an important regulator of host defense against C. rodentium by protecting the mucosa against ulcerations which can act as a microbial niche for the bacteria.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18453602      PMCID: PMC2696063          DOI: 10.4049/jimmunol.180.10.6816

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  55 in total

1.  IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice.

Authors:  D Aderka; J M Le; J Vilcek
Journal:  J Immunol       Date:  1989-12-01       Impact factor: 5.422

2.  Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor beta inhibit acute inflammation.

Authors:  T R Ulich; S Yin; K Guo; E S Yi; D Remick; J del Castillo
Journal:  Am J Pathol       Date:  1991-05       Impact factor: 4.307

3.  Organ specificity, colonization and clearance dynamics in vivo following oral challenges with the murine pathogen Citrobacter rodentium.

Authors:  Siouxsie Wiles; Simon Clare; James Harker; Alan Huett; Douglas Young; Gordon Dougan; Gad Frankel
Journal:  Cell Microbiol       Date:  2004-10       Impact factor: 3.715

4.  Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice.

Authors:  Yuji Naito; Tomohisa Takagi; Kazuhiko Uchiyama; Masaaki Kuroda; Satoshi Kokura; Hiroshi Ichikawa; Rie Yanagisawa; Ken-Ichiro Inoue; Hirohisa Takano; Masahiko Satoh; Norimasa Yoshida; Takeshi Okanoue; Toshikazu Yoshikawa
Journal:  Int J Mol Med       Date:  2004-08       Impact factor: 4.101

5.  IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer.

Authors:  Florian R Greten; Lars Eckmann; Tim F Greten; Jin Mo Park; Zhi-Wei Li; Laurence J Egan; Martin F Kagnoff; Michael Karin
Journal:  Cell       Date:  2004-08-06       Impact factor: 41.582

6.  Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia.

Authors:  S A Dalrymple; L A Lucian; R Slattery; T McNeil; D M Aud; S Fuchino; F Lee; R Murray
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

7.  The ultrastructure of transmissible murine colonic hyperplasia.

Authors:  E Johnson; S W Barthold
Journal:  Am J Pathol       Date:  1979-11       Impact factor: 4.307

8.  Increased and long-term generation of dendritic cells with reduced function from IL-6-deficient bone marrow.

Authors:  Joshua I Bleier; Venu G Pillarisetty; Alaap B Shah; Ronald P DeMatteo
Journal:  J Immunol       Date:  2004-06-15       Impact factor: 5.422

9.  Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin.

Authors:  T Hirano; K Yasukawa; H Harada; T Taga; Y Watanabe; T Matsuda; S Kashiwamura; K Nakajima; K Koyama; A Iwamatsu
Journal:  Nature       Date:  1986 Nov 6-12       Impact factor: 49.962

10.  The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells.

Authors:  A Muraguchi; T Hirano; B Tang; T Matsuda; Y Horii; K Nakajima; T Kishimoto
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

View more
  94 in total

1.  Tumor development in murine ulcerative colitis depends on MyD88 signaling of colonic F4/80+CD11b(high)Gr1(low) macrophages.

Authors:  Gabriela Schiechl; Bernhard Bauer; Ivan Fuss; Sven A Lang; Christian Moser; Petra Ruemmele; Stefan Rose-John; Markus F Neurath; Edward K Geissler; Hans-Jürgen Schlitt; Warren Strober; Stefan Fichtner-Feigl
Journal:  J Clin Invest       Date:  2011-04-25       Impact factor: 14.808

Review 2.  Citrobacter rodentium: a model enteropathogen for understanding the interplay of innate and adaptive components of type 3 immunity.

Authors:  D J Silberger; C L Zindl; C T Weaver
Journal:  Mucosal Immunol       Date:  2017-06-14       Impact factor: 7.313

Review 3.  Precarious balance: Th17 cells in host defense.

Authors:  Ariana Peck; Elizabeth D Mellins
Journal:  Infect Immun       Date:  2009-11-09       Impact factor: 3.441

4.  Absence of specific alternatively spliced exon of CD44 in macrophages prevents colitis.

Authors:  B M Wittig; R Sabat; P Holzlöhner; E Witte-Händel; K Heilmann; K Witte; J Triebus; A Tzankov; J D Laman; B Bokemeyer; L Terracciano; C Schwärzler; H Kohler; R Volkmer; C Loddenkemper; K Wolk; U Hoffmann; U Günthert
Journal:  Mucosal Immunol       Date:  2017-11-29       Impact factor: 7.313

5.  Interleukin-1 receptor signaling protects mice from lethal intestinal damage caused by the attaching and effacing pathogen Citrobacter rodentium.

Authors:  Sarah L Lebeis; Kimberly R Powell; Didier Merlin; Melanie A Sherman; Daniel Kalman
Journal:  Infect Immun       Date:  2008-12-15       Impact factor: 3.441

6.  The effects of probiotic supplementation on the gene expressions of immune cell surface markers and levels of antibodies and pro-inflammatory cytokines in human milk.

Authors:  Veronique Demers-Mathieu; Gabrielle B Mathijssen; Ciera DaPra; Elena Medo
Journal:  J Perinatol       Date:  2020-11-18       Impact factor: 2.521

Review 7.  Functions of innate immune cells and commensal bacteria in gut homeostasis.

Authors:  Hisako Kayama; Kiyoshi Takeda
Journal:  J Biochem       Date:  2015-11-27       Impact factor: 3.387

8.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

Authors:  Sergei Grivennikov; Eliad Karin; Janos Terzic; Daniel Mucida; Guann-Yi Yu; Sivakumar Vallabhapurapu; Jürgen Scheller; Stefan Rose-John; Hilde Cheroutre; Lars Eckmann; Michael Karin
Journal:  Cancer Cell       Date:  2009-02-03       Impact factor: 31.743

9.  Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa.

Authors:  Kirk S B Bergstrom; Vanessa Kissoon-Singh; Deanna L Gibson; Caixia Ma; Marinieve Montero; Ho Pan Sham; Natasha Ryz; Tina Huang; Anna Velcich; B Brett Finlay; Kris Chadee; Bruce A Vallance
Journal:  PLoS Pathog       Date:  2010-05-13       Impact factor: 6.823

10.  A role for CD47 in the development of experimental colitis mediated by SIRPalpha+CD103- dendritic cells.

Authors:  Genevieve Fortin; Marianne Raymond; Vu Quang Van; Manuel Rubio; Patrick Gautier; Marika Sarfati; Denis Franchimont
Journal:  J Exp Med       Date:  2009-08-24       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.